Cargando…
Erratum. Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study. Diabetes Care 2021;44:1613–1621
Autores principales: | Petrova, Nina L., Donaldson, Nicholas K., Bates, Maureen, Tang, Wegin, Jemmott, Timothy, Morris, Victoria, Dew, Tracy, Meacock, Lisa, Elias, David A., Moniz, Cajetan F., Edmonds, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931957/ https://www.ncbi.nlm.nih.gov/pubmed/34479958 http://dx.doi.org/10.2337/dc21-er11 |
Ejemplares similares
-
Effect of Recombinant Human Parathyroid Hormone (1-84) on Resolution of Active Charcot Neuro-osteoarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
por: Petrova, Nina L., et al.
Publicado: (2021) -
A Prospective Study of Calcaneal Bone Mineral Density in Acute Charcot Osteoarthropathy
por: Petrova, Nina L., et al.
Publicado: (2010) -
Association Among Sarcoidosis, Type 1 Diabetes, and Charcot Neuro-Osteoarthropathy
por: Pitocco, Dario, et al.
Publicado: (2009) -
Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy
por: Petrova, Nina L., et al.
Publicado: (2015) -
Novel Semiquantitative Bone Marrow Oedema Score and Fracture Score for the Magnetic Resonance Imaging Assessment of the Active Charcot Foot in Diabetes
por: Meacock, L., et al.
Publicado: (2017)